Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
KAS-ATAC Sequencing for Accessible ssDNA Genomes
2026-08-27
The KAS-ATAC protocol combines N3-kethoxal labeling of single-stranded DNA with Tn5-based chromatin accessibility profiling to identify genomic regions that are both physically accessible and contain ssDNA structures. The workflow provides a practical route for integrating transcription-associated DNA structures with regulatory chromatin maps, while its interpretation requires careful attention to labeling chemistry, native chromatin handling, enrichment, and sequencing biases.
-
EdU Imaging Kits (488): 5 Lab Scenarios
2026-08-26
This scenario-based guide explains how EdU Imaging Kits (488), SKU K1175, can improve S-phase DNA synthesis measurement when metabolic assays, BrdU workflows, or inconsistent sample handling create ambiguity. It covers assay design, click-chemistry workflow, interpretation, and practical vendor-selection criteria for microscopy and flow cytometry.
-
From ISG20 Signal to Atherosclerosis Mechanism
2026-08-26
A translational framework for converting ISG20 and CLEC5A observations into spatially resolved, experimentally defensible atherosclerosis evidence. The article explains how HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody can strengthen fluorescence workflows across macrophage, endothelial, and plaque studies while addressing multiplexing, controls, and assay reproducibility.
-
RG108: A Practical Guide to DNMT Assay Design
2026-08-26
RG108 is a DNA methyltransferase inhibitor suited to mechanistic epigenetics and cancer research. This guide focuses on interpreting biochemical versus cellular data, selecting orthogonal endpoints, and applying lessons from a recent antiviral mechanism study without overstating what RG108 can prove.
-
Difloxacin HCl: Assay Workflows for Resistance Research
2026-08-25
Difloxacin HCl supports two distinct research paths: organism-level antimicrobial susceptibility testing and exploratory multidrug resistance reversal in neuroblastoma models. This guide connects formulation, assay controls, and troubleshooting with a checkpoint-regulation study without overstating evidence across biological systems.
-
CX-5461: Mapping Pol I Stress to Tumor Cell Fate
2026-08-24
CX-5461 is an RNA polymerase I inhibitor that connects ribosome biogenesis disruption with DNA damage, mitotic failure, autophagy, and senescence. This guide provides an assay-centered framework for interpreting tumor-cell responses and designing more informative cancer research workflows.
-
LRPPRC–Dasatinib Synergy in OXPHOS Cancer
2026-08-24
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition, revealing complementary suppression of nuclear- and mitochondrial genome-encoded oxidative phosphorylation programs. Its screening and mechanistic design provide a rationale for dual-genome OXPHOS disruption while also highlighting the need for biomarker-guided validation beyond cell models.
-
Tofacitinib Citrate: From JAK3 to Vascular Insight
2026-08-23
A translational perspective on Tofacitinib citrate and CP-690550 citrate, connecting JAK3-preferring immune modulation with concentration-aware endothelial experiments, comparative JAK inhibitor biology, and practical study design.
-
Vernakalant for Rapid Atrial Fibrillation Conversion
2026-08-22
This phase 3 randomized trial showed that intravenous vernakalant rapidly converted recent-onset atrial fibrillation to sinus rhythm, with a substantially higher response than placebo and a median conversion time of 11 minutes. Its main contribution was clinical validation of an atrium-oriented electrophysiological strategy, while the safety findings underscore the need for careful patient selection and monitoring.
-
HYPK, NatA, and Ribosome Exchange in Protein Acetylation
2026-08-21
The reference study shows that HYPK promotes global N-terminal acetylation not by simply increasing NatA catalysis, but by accelerating NatA exchange between ribosomes. This kinetic mechanism explains how sub-stoichiometric NatA can modify a broad nascent proteome and establishes ribosome residence time as a central variable in cotranslational protein maturation.
-
Rotigotine’s Antidepressant Activity in Rat Models
2026-08-20
The reference study examined rotigotine across several rat models of anxiety and depression, showing antidepressant-like effects at lower doses while identifying locomotor stimulation as an important high-dose confound. Its multi-model design provides a useful framework for interpreting dopamine-dependent behavioral effects in Parkinson’s disease research.
-
Self-Amplifying RNA for Influenza Dose Sparing
2026-08-20
This 2026 study shows that RNA vaccine performance depends strongly on both influenza subtype and platform design. Self-amplifying RNA produced durable antibody responses and complete homologous influenza B protection at a low dose in mice, overcoming a weakness observed with conventional nucleoside-modified mRNA.
-
GI 254023X: Precision in ADAM10 Translation
2026-08-19
GI 254023X illustrates how selective ADAM10 inhibition can connect sheddase biology with actionable translational experiments in signaling and vascular injury. This thought-leadership perspective outlines a mechanism-first workflow, interprets cross-domain lessons from partial BACE inhibition, and defines the evidence needed to move ADAM10 research beyond product-page pharmacology.
-
Dorsomorphin 2HCl: AMPK Inhibitor Workflows
2026-08-19
Dorsomorphin 2HCl is a practical pharmacologic probe for testing whether AMPK activation drives metabolic phenotypes, while also enabling BMP, osteogenesis, and hepcidin studies. This guide translates a recent probiotic–liver study into executable assay workflows, controls, and troubleshooting strategies for stronger mechanistic interpretation.
-
Safe DNA Gel Stain for Safer Gel Workflows
2026-08-18
Safe DNA Gel Stain combines sensitive DNA and RNA detection with blue-light compatibility, helping laboratories reduce dependence on ethidium bromide and damaging UV exposure. This practical guide covers gel preparation, post-stain recovery, cloning workflows, assay selection, and troubleshooting for reproducible nucleic acid visualization.